Cargando…
Exploring direct and indirect targets of current antileishmanial drugs using a novel thermal proteomics profiling approach
Visceral leishmaniasis (VL), caused by Leishmania infantum, is an oft-fatal neglected tropical disease. In the absence of an effective vaccine, the control of leishmaniasis relies exclusively on chemotherapy. Due to the lack of established molecular/genetic markers denoting parasite resistance, clin...
Autores principales: | Ibarra-Meneses, Ana Victoria, Corbeil, Audrey, Wagner, Victoria, Beaudry, Francis, do Monte-Neto, Rubens L., Fernandez-Prada, Christopher |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9381709/ https://www.ncbi.nlm.nih.gov/pubmed/35992178 http://dx.doi.org/10.3389/fcimb.2022.954144 |
Ejemplares similares
-
Identification of asymptomatic Leishmania infections: a scoping review
por: Ibarra-Meneses, Ana Victoria, et al.
Publicado: (2022) -
Metalloprotease Gp63-Targeting Novel Glycoside Exhibits Potential Antileishmanial Activity
por: Chakrabarti, Amrita, et al.
Publicado: (2022) -
Three different mutations in the DNA topoisomerase 1B in Leishmania infantum contribute to resistance to antitumor drug topotecan
por: Rosa-Teijeiro, Chloé, et al.
Publicado: (2021) -
Of Drugs and Trypanosomatids: New Tools and Knowledge to Reduce Bottlenecks in Drug Discovery
por: Bhattacharya, Arijit, et al.
Publicado: (2020) -
Editorial: Direct and Indirect Interactions of HIV With Host Cells
por: Tsukamoto, Tetsuo, et al.
Publicado: (2021)